Back to articles
Comparative guide · 6 min read

NAC vs glutathione — supplement the precursor or the molecule itself?

Updated 2026-05-09 · Reviewed by SupplementScore editors · No sponsorships

Glutathione is the body's master intracellular antioxidant. The intuitive supplement strategy is to swallow glutathione directly. The biologically more efficient strategy is to swallow its rate-limiting precursor — N-acetyl cysteine (NAC) — and let the body assemble glutathione where it's actually needed. The trial evidence sides decisively with the precursor approach, which is also far cheaper.

Quick verdict

GoalBetter choiceWhy
Raising tissue glutathione levels NAC Cysteine is the rate-limiting amino acid in glutathione synthesis. NAC reliably raises hepatic and erythrocyte glutathione in trials.
Acetaminophen overdose / acute liver protection NAC NAC is on the WHO essential medicines list for paracetamol toxicity. Glutathione has no equivalent role.
Mucolytic effect (chronic bronchitis, COPD) NAC Multiple meta-analyses support 600 mg twice daily for reducing exacerbations. Glutathione doesn't have this evidence base.
PCOS / insulin sensitivity NAC Several trials at 1.8–3 g/day show benefits on cycle regularity and metabolic markers. Glutathione has minimal data here.
Skin lightening / cosmetic glutathione marketing Neither (oral) Both have weak evidence for skin lightening; neither beats topical sunscreen + tyrosinase inhibitors.
Cost per effective dose NAC $0.20–0.40/day for 1.2 g NAC. Liposomal glutathione runs $1–3/day at clinically suggested doses.

How they compare on the things that matter

Mechanism — why the precursor often wins

Glutathione is a tripeptide of cysteine, glycine, and glutamate. The bottleneck enzyme in its synthesis is glutamate-cysteine ligase, and the rate-limiting input is cysteine itself. Supplementing free cysteine is impractical because cysteine is unstable and oxidises rapidly; NAC (N-acetyl cysteine) is a more stable form that the body deacetylates to release cysteine, which is then used for glutathione synthesis.

Direct oral glutathione has historically had a bioavailability problem: glutathione is hydrolysed in the GI tract back into its component amino acids before being absorbed. Liposomal and S-acetyl-glutathione formulations claim to bypass this barrier, with some pharmacokinetic data supporting modest increases in blood glutathione. Whether this translates to higher intracellular glutathione where it's biologically active is a different and less-resolved question.

Evidence base by clinical endpoint

Practical rule. If your goal involves raising glutathione for an antioxidant or liver-related reason, NAC is the better-evidenced and far cheaper option. Direct oral glutathione is a niche product with marketing claims well ahead of clinical evidence.

The GlyNAC twist

A growing trial literature is testing GlyNAC — glycine combined with NAC — on the rationale that older adults are deficient not just in cysteine but also in glycine, and supplementing both raises glutathione more than either alone. The Sekhar lab trials in older adults are encouraging on muscle strength, walking speed, and oxidative stress markers. GlyNAC is reasonable to consider for adults >60 with diagnosed sarcopenia or oxidative-stress-related conditions; for younger adults, plain NAC plus dietary glycine sources is sufficient.

Safety and side-effects

NAC is well-tolerated at standard doses. Common side-effects are mild GI upset and sulphur-smelling burps (cysteine releases hydrogen sulphide). Rare but real: NAC can cause headache and, very rarely, paradoxical bronchospasm in asthma. Note also that the FDA briefly questioned NAC's status as a dietary supplement in 2020–2021; that issue has been resolved, but it explains why some retailers transiently dropped the product.

Oral glutathione is generally well-tolerated. The main caution is that quality varies enormously across "liposomal" or "acetylated" products — the actual encapsulation efficiency and bioavailability claim is rarely independently verified. If you choose oral glutathione, third-party testing matters more here than for most categories.

What the price difference buys you

Generic NAC at 600 mg, twice daily, runs about $10–20 for a month's supply. Liposomal glutathione at the manufacturer-suggested dose is typically $30–80 per month. For roughly 5–10× the price, you gain a less established mechanism and weaker clinical evidence. For most users, the math favours NAC.

Who should not take each

NAC should be used cautiously in people with severe asthma (rare bronchospasm risk) and is generally not recommended for routine use during pregnancy without supervision (although it has been used safely in pregnancy for specific indications). NAC at high doses can mildly inhibit blood clotting; relevant for anyone on anticoagulants or before surgery (pause 1–2 weeks pre-op).

Direct glutathione has limited contraindication data simply because the long-term oral safety dataset is smaller. It is generally considered safe at typical dietary supplement doses. People considering high-dose glutathione for cosmetic skin-lightening should know the topic remains medically controversial and that injectable glutathione has been associated with serious adverse events.

What we'd actually buy

For raising glutathione, supporting acetaminophen-stressed liver, mucolytic effect, or as a psychiatric adjunct: NAC at 600 mg twice daily, third-party tested, with food. For older adults seeking the muscle/oxidative-stress benefits of the GlyNAC literature: a GlyNAC product at the trial-validated 1.2 g cysteine equivalent + 1.2 g glycine daily.

If you specifically want direct glutathione and are willing to pay the premium: a third-party tested liposomal product at ~500 mg/day, taken on an empty stomach. Evaluate after 8–12 weeks against tracked endpoints; this product category has high price variance and uneven quality.

Sources

Read more: